995 results on '"Damotte, Diane"'
Search Results
2. Tumor stage-driven disruption of NK cell maturation in human and murine tumors
3. The tumor immune microenvironment of SCLC is not associated with its molecular subtypes
4. Relationship between energetic gap and sensitivity to anti-programmed cell death 1 immune checkpoint inhibitors in non-small cell lung cancer patients: The ELY-2 study
5. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
6. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
7. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors
8. Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors
9. Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience
10. The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
11. SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils
12. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC
13. Prognostic impact of inflammation in malignant pleural mesothelioma: A large-scale analysis of consecutive patients
14. Differential predictive value of resident memory CD8+T cell subpopulations in non-small-cell lung cancer patients treated by immunotherapy
15. Size and Predictive Factors of Microscopic Tumor Extension in Locally Advanced Non-Small Cell Lung Cancer
16. Évaluation de la réponse pathologique après thérapie néoadjuvante dans les cancers pulmonaires
17. Prise en charge chirurgicale du cancer bronchique non à petites cellules opérable : vers de nouveaux paradigmes
18. Les réarrangements moléculaires : cibles thérapeutiques en cancérologie thoracique
19. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center
20. Les tumeurs thoraciques SMARCA4 déficientes : une nouvelle entité
21. Supplementary Fig. S2 from A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non–small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics
22. Supplementary Table S5 from A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non–small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics
23. Data from A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non–small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics
24. Mitochondrial metabolism sustains CD8+T cell migration for an efficient infiltration into solid tumors
25. A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non–small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics
26. Recommandations SFP pour la prise en charge macroscopique des pièces de résections de tumeurs pulmonaires
27. Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer
28. Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors
29. Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors.
30. Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangement
31. Usefulness of an RNA extraction-free test for the multiplexed detection of ALK , ROS1 , and RET Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers
32. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
33. Tests immunohistochimiques PD-L1 dans les cancers du poumon non à petites cellules : recommandations par le groupe PATTERN de pathologistes thoraciques
34. Lung Involvement in Chronic Schistosomiasis with Bladder Squamous Cell Carcinoma
35. Diversity of Regulatory CD4 + T Cells Controlling Distinct Organ-Specific Autoimmune Diseases
36. Efficacité des inhibiteurs du checkpoint immunitaire PD-1/PD-L1 et testing PD-L1 dans les cancers thoraciques
37. Les immune-checkpoints dans les hémopathies
38. Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
39. Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought
40. Data from The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
41. Supplementary Data 1 from The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
42. Supplementary Table from Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors
43. Movie S2 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
44. Supplementary Tables from Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade
45. Supplementary Data from Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment
46. Supplementary Figures from Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade
47. Figure S1 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
48. Data from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
49. Data from Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade
50. Supplementary Table 1 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.